http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102579459-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93c2aafeb1bcb1019daee345cc8f141 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ec48b24885c484cd758715fd734108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c59b06d29f3a00777bc2737a0b9757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_322d0930e5a3dfa67d0da0c3f19d2c52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcedc3b033987687257723f764bb0942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed08b7fa92e6e4b133f42549c4e71100 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ebf7fd0f2cc56482bbd981d98b719bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_805761a16acdfc5dd692b0be8188b09e |
| publicationDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102579459-B |
| titleOfInvention | Application of anwuweizic acid in preparation of medicine for preventing and treating hepatitis virus |
| abstract | The invention provides an application of anwuweizic acid in preparation of a medicine for preventing and treating hepatitis virus, wherein anwuweizic acid is a tetracyclic triterpenoid compound. The invention also provides an application of anwuweizic acid in preparation of food and health care products for protecting liver. According to the invention, the application of the tetracyclic triterpenoid compound namely anwuweizic acid in preparing the medicine for resisting hepatitis B virus (HBV) and hepatitis C virus (HCV) is provided; and the test result proves that the tetracyclic triterpenoid compound has remarkable activity in the aspect of resisting HBV and HCV, and is especially capable of inhibiting HCV to invade target cells, thus being used for preparing the medicine for resisting HBV and HCV. The invention provides a new source for finding out the medicine for resisting HBV and HCV. |
| priorityDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.